-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Cuts SAVE Registry Requirement to 50 Patients for SeaStar Medical’s QUELIMMUNE Therapy

Reuters·12/02/2025 13:27:12

Please log in to view news